| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |